Image of the Day: Switch Gears

A gene responsible for the free-moving, primitive nature of fetal cells is expressed in some breast cancer cells in mice and humans.

Written bySukanya Charuchandra
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: Left panel: Considerable numbers of invasive cancer cells with Sox10 (red) in them can be found outside of mouse tumors in vivo (green cells, outlined). Right panel: The invasive cells are proximal to blood vessels (white).
SALK INSTITUTE/SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE

Agene known to be active in fetal cells is also expressed in aggressive forms of breast cancer, pointing to a possible explanation for cancer cells’ ability to regain the potential to evolve into other types and metastasize to different regions in the body. The findings were published last month (August 30) in Cancer Cell.

The gene in question, Sox10, controls several processes, including cell development and movement, as a transcription factor.

The researchers noticed that breast cancer cells from humans and mice with abundant Sox10 reverted to undifferentiated variants that turned invasive and freely migrated. In a mouse experiment, they observed that disrupting Sox10 function stopped cancer formation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies